SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Perlegen
AFFX 14.010.0%Apr 1 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (7)4/11/2006 6:08:54 AM
From: Mike McFarland  Read Replies (2) of 27
 
I guess I sorta glossed over and don't really
comprehend the difference between genomics for
stratifying clinical trials and screening studies
for identifying leads. The former may be a viable
business for rescuing drugs however. When I pair
"lead optimization" or "lead validation" with
Perlgen, google does not seem to point me to good
articles.

This article is a year old and happens to
be about Genizon, but it is one for the Perlegen
folder too, ilmn genotyping as well.

bio-itworld.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News